Originally discovered as a regulator of glycogen metabolism, GSK3β has since been implicated in neural development as well as pathological processes associated with chronic diseases including diabetes, neurodegeneration, and cancer (see reviews [65,66,67,68]). This evidence concerns the gene GSK3B and diabetes mellitus.